Tina Sehm
Affiliations: | 2011- | Translational Cell Biology | Universitätsklinikum Erlangen |
Google:
"Tina Sehm"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baecker J, Wartchow K, Sehm T, et al. (2019) Treatment with the Neurotrophic Protein S100B Increases Synaptogenesis Following Traumatic Brain Injury. Journal of Neurotrauma |
| Galli R, Uckermann O, Sehm T, et al. (2019) Identification of distinctive features in human intracranial tumors by label-free nonlinear multimodal microscopy. Journal of Biophotonics. e201800465 |
| Dahlmanns M, Yakubov E, Chen D, et al. (2017) Chemotherapeutic xCT inhibitors sorafenib and erastin unraveled with the synaptic optogenetic function analysis tool. Cell Death Discovery. 3: 17030 |
| Sehm T, Rauh M, Wiendieck K, et al. (2016) Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget |
| Ghoochani A, Hatipoglu Majernik G, Sehm T, et al. (2016) Cabazitaxel operates anti-metastatic and cytotoxic via apoptosis induction and stalls brain tumor angiogenesis. Oncotarget. 7: 38306-38318 |
| Sehm T, Fan Z, Ghoochani A, et al. (2016) Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget |
| Fan Z, Bittermann-Rummel P, Yakubov E, et al. (2016) PRG3 induces Ras-dependent oncogenic cooperation in gliomas. Oncotarget |
| Ghoochani A, Yakubov E, Sehm T, et al. (2015) A versatile ex vivo technique for assaying tumor angiogenesis and microglia in the brain. Oncotarget |
| Hatipoglu G, Hock SW, Weiss R, et al. (2015) Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment. Cancer Science. 106: 160-70 |
| Sehm T, Fan Z, Weiss R, et al. (2014) The impact of dietary isoflavonoids on malignant brain tumors. Cancer Medicine. 3: 865-77 |